Effect of Pelvic Floor and Hip Muscle Strengthening in the Treatment of Stress Urinary Incontinence: A Randomized Clinical Trial

Carregando...
Imagem de Miniatura
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
MOSBY-ELSEVIER
Citação
JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS, v.43, n.3, p.247-256, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To investigate the effectiveness of strengthening the hip muscles in addition to strengthening the pelvic floor muscles (PFM) in the treatment of stress urinary incontinence. Methods: This study used a prospective, assessor-blind, randomized clinical trial with parallel groups. We randomly allocated 47 individuals with stress urinary incontinence to 2 groups: 1 performing only pelvic floor strengthening exercises (PF, n = 21) and the other performing pelvic floor strengthening exercises plus exercises for the gluteus maximus and medius and hip adductor muscles (PFH, n = 22). Four individuals did not complete the study. Frequency of urine leakage was the primary outcome (3-day voiding diary and a follow-up voiding diary). Secondary outcomes were pelvic floor muscle strength (Ortiz scale, PERFECT scheme [Oxford Scale], and perineometry) and quality of life (QoL; International Consultation on Incontinence Questionnaire-Short Form and King's Health Questionnaire), which were evaluated by a blinded assessor before and after 20 sessions over 10 weeks. Results: Regarding the daily frequency of urine loss evaluated by the follow-up voiding diary, an effect of group was observed (P < .001), with the PFH group showing a significant decrease in daily loss frequency, although no significant differences were found in the comparison between groups for the 3-day voiding diary, QoL, or functional assessment of the PFM. Conclusion: Strengthening the PFM together with the hip synergic muscles showed better results for frequency of daily urine loss throughout the sessions, although there was no accompanying superiority in improvement of strength, perineometry, or QoL over the group that performed only PFM-strengthening exercises.
Palavras-chave
Women's Health, Urinary Incontinence, Stress, Physical Therapy Modalities, Rehabilitation, Pelvic Floor, Hip
Referências
  1. Avery K., 2001, Neurourology and Urodynamics, V20, P510
  2. Bo K, 2004, SPORTS MED, V34, P451
  3. BO K, 1994, NEUROUROL URODYNAM, V13, P35, DOI 10.1002/nau.1930130106
  4. Bo K, 2012, WORLD J UROL, V30, P437, DOI 10.1007/s00345-011-0779-8
  5. Bright E, 2011, NEUROUROL URODYNAM, V30, P348, DOI 10.1002/nau.20994
  6. Contreras Ortiz O, 1996, B SOC LATINOAM UROGI, V1, P5
  7. DEBLOK S, 1982, ACTA MORPHOL NEER SC, V20, P347
  8. Zanetti MRD, 2007, SAO PAULO MED J, V125, P265, DOI 10.1590/S1516-31802007000500003
  9. Dumoulin C, 2010, COCHRANE DB SYST REV, V1
  10. Dumoulin C, 2011, NEUROUROL URODYNAM, V30, P746, DOI 10.1002/nau.21104
  11. Godl-Purrer B., 2006, THE PELVIC FLOOR, P252
  12. Groutz A, 2000, J UROLOGY, V164, P698, DOI 10.1016/S0022-5347(05)67284-9
  13. Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x
  14. Ferreira CHJ, 2011, PHYSIOTHERAPY, V97, P132, DOI 10.1016/j.physio.2010.06.007
  15. Kelleher CJ, 1997, BRIT J OBSTET GYNAEC, V104, P1374, DOI 10.1111/j.1471-0528.1997.tb11006.x
  16. Laycock J, 2001, PHYSIOTHERAPY, V87, P631, DOI 10.1016/S0031-9406(05)61108-X
  17. Madill SJ, 2009, INT UROGYNECOL J, V20, P447, DOI 10.1007/s00192-008-0800-y
  18. McLean L, 2013, NEUROUROL URODYNAM, V32, P1096, DOI 10.1002/nau.22343
  19. NORTON PA, 1994, OBSTET GYNECOL, V84, P770
  20. Tamanini JTN, 2018, NEUROUROL URODYNAM, V37, P466, DOI 10.1002/nau.23331
  21. Pedersen LS, 2017, ACTA OBSTET GYN SCAN, V96, P939, DOI 10.1111/aogs.13149
  22. Price N, 2010, MATURITAS, V67, P309, DOI 10.1016/j.maturitas.2010.08.004
  23. Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670
  24. Riccetto C, 2005, J UROLOGY, V173, P357
  25. Smith MD, 2007, NEUROUROL URODYNAM, V26, P377, DOI 10.1002/nau.20336
  26. Soljanik I, 2012, ARCH GYNECOL OBSTET, V286, P931, DOI 10.1007/s00404-012-2377-4
  27. Tamanini JTN, 2004, REV SAUDE PUBL, V38, P438, DOI 10.1590/S0034-89102004000300015
  28. Tamanini JTN, 2003, REV SAUDE PUBL, V37, P203, DOI 10.1590/S0034-89102003000200007
  29. Teng M, 2018, ANN PHYS REHABIL MED, V61, P345, DOI 10.1016/j.rehab.2018.06.006
  30. Thuroff JW, 2011, EUR UROL, V59, P387, DOI 10.1016/j.eururo.2010.11.021
  31. Tsai YC, 2009, INT J NURS STUD, V46, P1181, DOI 10.1016/j.ijnurstu.2009.03.003
  32. Underwood D, 2011, INT UROGYNECOL J S2, V22, pS964
  33. Verghese T, 2014, INT J UROL, V21, P25, DOI 10.1111/iju.12238
  34. Yap TL, 2007, BJU INT, V99, P9, DOI 10.1111/j.1464-410X.2006.06499.x
  35. Yuen TS, 2017, J MANIP PHYSIOL THER, V40, P587, DOI 10.1016/j.jmpt.2017.07.003